(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

Q-BOND

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

Q-BOND

ST13

US500000079057369

Classe

1, 5

Pedido

79057369

Registro

3737065

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

62

Atualização mais recente

15/01/2021

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5

Data de depósito

25/03/2008

Data de registro

12/01/2010

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

13/05/2020

Última transação

13/05/2020

Escritório responsável

United States Patent and Trademark Office

Código da situação

706

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

Hilden, DE

Examinador

MITTLER,ROBIN M

Unidade examinadora

M80

Localização atual

GENERIC WEB UPDATE

Titulares e representantes

Titulares

QIAGEN GmbH
QIAGEN GmbH

Representantes

Victoria Friedman Dennemeyer & Associates, LLC

Classificação técnica

Classes Nice

Classe 1Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

chemicalbiochemical and biotechnological preparations for industrial and scientific purposesdiagnostic preparations except for human or veterinary medical purposes; non-medical reagents and solvents for scientific and medical research usefor sample preparationfor markingseparatingisolatingpurifyingamplifying and analyzing natural or synthetic biopolymersin particular nucleic acidsoligonucleotides proteinsmacromolecules and biologically active substances ; kits comprising chemical preparations for scientific purposesfor the preparation of samplesfor the markingseparatingisolatingpurifyingamplifying and analysis of natural or synthetic biopolymersin particular nucleic acidsoligonucleotides proteinsmacromolecules and biologically active substancesin particular nucleic acids of biological or biochemical samples material

Classe 5

diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; diagnostic preparations for medical and veterinary purposesin particular diagnosticsin particular for sample preparation and for markingseparatingisolatingpurifyingamplifying and analysis of biopolymersin particular nucleic acidsoligonucleotidesproteinsmacromolecules and biologically active substances; chemicalbiochemical and biotechnological preparationsin particular reagents for medical usefor sample preparationfor the conduction of markingseparatingisolatingpurifyingamplifying and analysis methods for biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substances for diagnostic purposes; in vitro diagnostic preparations for medical purposeskits comprising diagnostic preparations for medical or veterinary-diagnostic purposesin particular for sample preparationfor markingseparatingisolatingpurifyingamplifying and analysis of biopolymersin particular nucleic acidsoligonucleotidesproteinsmacromolecules and biologically active substancesin particular nucleic acids of biological or biochemical sample material; all purpose disinfectants

Publicações

Histórico de despachos e eventos da marca no USPTO.

62 publicações encontradas

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

15/01/2021

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

13/01/2021

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

13/05/2020

71AG

REGISTERED-SEC.71 ACCEPTED

13/05/2020

PR71

POST REGISTRATION ACTION MAILED - SEC.71

29/02/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/02/2020

ES71

TEAS SECTION 71 RECEIVED

03/01/2020

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

12/01/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

18/10/2018

RNWL

INTERNATIONAL REGISTRATION RENEWED

26/04/2018

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

23/06/2017

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

28/04/2017

INPC

INVALIDATION PROCESSED

28/04/2017

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

30/11/2016

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

30/03/2016

CORV

REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD

30/03/2016

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

30/03/2016

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

14/03/2016

PR75

POST REGISTRATION ACTION MAILED - SEC. 71 & 15

28/01/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

21/01/2016

ES75

TEAS SECTION 71 & 15 RECEIVED

17/12/2015

NREP

NEW REPRESENTATIVE AT IB RECEIVED

22/08/2014

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/07/2013

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/02/2013

FICS

FINAL DISPOSITION NOTICE SENT TO IB

14/05/2010

FIMP

FINAL DISPOSITION PROCESSED

13/05/2010

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/04/2010

R.PR

REGISTERED-PRINCIPAL REGISTER

12/01/2010

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

27/10/2009

PUBO

PUBLISHED FOR OPPOSITION

27/10/2009

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

23/09/2009

ALIE

ASSIGNED TO LIE

23/09/2009

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/09/2009

XAEC

EXAMINER'S AMENDMENT ENTERED

12/09/2009

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/09/2009

GNEA

EXAMINERS AMENDMENT E-MAILED

12/09/2009

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/09/2009

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/09/2009

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/09/2009

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

10/09/2009

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

04/06/2009

GNFR

FINAL REFUSAL E-MAILED

04/06/2009

CNFR

FINAL REFUSAL WRITTEN

04/06/2009

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

13/05/2009

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

13/05/2009

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/05/2009

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/05/2009

NAUD

NOTICE OF UNRESPONSIVE AMENDMENT - MAILED

15/04/2009

NAUD

REPORT UNRESPONSIVE AMENDMENT - COMPLETED

15/04/2009

LIMS

LIMITATION OF GOODS/SERVICES FROM IB ENTERED

25/03/2009

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

19/03/2009

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/03/2009

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/03/2009

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/03/2009

RFNT

REFUSAL PROCESSED BY IB

17/10/2008

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

22/09/2008

RFRR

REFUSAL PROCESSED BY MPU

22/09/2008

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

20/09/2008

CNRT

NON-FINAL ACTION WRITTEN

19/09/2008

DOCK

ASSIGNED TO EXAMINER

12/09/2008

NWAP

NEW APPLICATION ENTERED

12/09/2008

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/09/2008

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace Q-BOND ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.